Gastric Sleeve vs Weight Loss Injections: Which Is Better?

In recent years, GLP-1 analogs (weekly injections such as GLP-1 receptor agonists and dual GIP/GLP-1 agonists) have gained attention as a "non-surgical" alternative for weight loss. At Dr. César Hernández Elenes' office in Mexicali, many patients arrive with the question: is it better to inject myself or have the gastric sleeve? The answer is not the same for everyone, and here we explain the key differences.

How does each treatment work?

Injections are drugs that mimic a natural intestinal hormone (GLP-1) that regulates appetite, slows gastric emptying and increases satiety. They are applied weekly, indefinitely. Gastric sleeve, on the other hand, is a surgical procedure that reduces the stomach size by approximately 80%, permanently removing the portion that produces ghrelin (the hunger hormone). It is a definitive anatomical modification, not a continuous medication.

Results and weight loss

Clinical studies show that GLP-1 analogs produce weight loss of 15-20% of initial body weight after 12-18 months of continuous use. Gastric sleeve produces loss of 60-70% of excess weight in the first year (approximately 25-30% of total weight), and results are sustained long-term with appropriate habit changes. For patients with severe obesity (BMI >35), bariatric surgery offers significantly greater and more durable results.

The dependence problem

This is the most important difference that is often overlooked: injections work while you use them. Studies show that upon discontinuing GLP-1 analogs, patients regain approximately two-thirds of the lost weight in the first year without medication. This makes the injectable treatment a lifelong therapy with sustained monthly costs. Gastric sleeve is definitive: a single intervention with long-lasting results.

Long-term cost comparison

Latest-generation weekly injections cost between $3,500 and $8,000 pesos per month in Mexico, depending on dose. Over 5 years, that represents between $210,000 and $480,000 pesos, with no guarantee of maintaining weight if discontinued. Gastric sleeve with Dr. César Hernández in Mexicali has a one-time cost significantly lower than long-term injectable treatment, with metabolic benefits maintained at no ongoing cost.

Side effects and tolerance

GLP-1 analogs frequently cause nausea, vomiting, diarrhea, constipation and reflux, especially when starting or increasing the dose. Some patients do not tolerate them and must discontinue. Gastric sleeve involves a 2-4 week recovery period with progressive diet, but once overcome, most patients do not experience long-term side effects. Perioperative mortality for gastric sleeve is less than 0.2% in certified centers.

Who is each treatment for?

Injections may be a reasonable option for patients with mild overweight (BMI 27-30) without comorbidities, or as a bridge before surgery in high-risk patients. Gastric sleeve is the best option for patients with obesity (BMI >30 with comorbidities, or BMI >35 without them) seeking definitive results, elimination of medications for type 2 diabetes and hypertension, and significant improvement in long-term quality of life.

The right decision is individual

There is no universal "best treatment". During consultation with Dr. César Hernández Elenes, your BMI, comorbidities, medical history, expectations and economic situation are evaluated to recommend the most appropriate option. In many cases, gastric sleeve offers the best balance between effectiveness, total cost and sustainability of results.